Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins

Endocrinology

Volumn 147, Issue 7, 2006, Pages 3586-3597

  Sidis, Yisrael ^a   Mukherjee, Abir ^a   Keutmann, Henry ^a   Delbaere, Anne ^a,b   Sadatsuki, Miyuki ^a   Schneyer, Alan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; FOLLISTATIN; FOLLISTATIN LIKE 3 PROTEIN; ISOPROTEIN; MEMBRANE PROTEIN; MYOSTATIN; OSTEOGENIC PROTEIN 1; PROTEOGLYCAN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOASSAY; BIOCHEMISTRY; CELL MEMBRANE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; HUMAN; HUMAN CELL; KINETICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TESTIS TUMOR; TISSUE DISTRIBUTION; TUMOR CELL;

ACTIVINS; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; FOLLISTATIN; FOLLISTATIN-RELATED PROTEINS; HUMANS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745175570     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0089     Document Type: Article

References (52)

1. Welt C, Sidis Y, Keutmann H, Schneyer A 2002 Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 227:724-752
2. Phillips DJ 2000 Regulation of activin's access to the cell: why is mother nature such a control freak? Bioessays 22:689-696
3. DePaulo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N 1991 Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Soc Exp Med Biol 200:500-512
4. Besecke LM, Guendner MJ, Sluss PA, Polak AG, Woodruff TK, Jameson JL, Bauer-Dantoin AC, Weiss J 1997 Pituitary follistatin regulates activin-mediated production of follicle-stimulating hormone during the rat estrous cycle. Endocrinology 138:2841-2848
5. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM 2003 Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 18:953-967
6. Guo Q, Kumar TR, Woodruff TW, Hadsell LA, DeMayo FJ, Matzuk MM 1998 Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 12:96-106
7. Takabe K, Wang L, Leal AM, MacConell LA, Wiater E, Tomiya T, Ohno A, Verma IM, Vale W 2003 Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology 38:1107-1115
8. Wankell M, Munz B, Hubner G, Hans W, Wolf E, Goppelt A, Werner S 2001 Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 20:5361-5372
9. Jones KL, Kretser DM, Patella S, Phillips DJ 2004 Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol 225:119-125
10. Matzuk MM, Lu N, Vogel HJ, Sellheyer K, Roop DR, Bradley A 1995 Multiple defects and perinatal death in mice deficient in follistatin. Nature 374:360-363
11. Yao HH, Matzuk MM, Jorgez CJ, Menke DB, Page DC, Swain A, Capel B 2004 Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 230:210-215
12. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying SY, Ling N, Guillemin R 1988 Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA 85:4218-4222
13. Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N, Titani K, Sugino H 1993 Molecular heterogeneity of follistatin, an activin-binding protein. J Biol Chem 68:15579-15587
14. Sumitomo S, Inouye S, Liu XJ, Ling N, Shimasaki S 1995 The heparin binding site of follistatin is involved in its interaction with activin. Biochem Biophys Res Commun 208:1-9
15. Inouye S, Ling N, Shimasaki S 1992 Localization of the heparin binding site of follistatin. Mol Cell Endocrinol 90:1-6
16. Nakamura T, Sugino K, Titani K, Sugino H 1991 Follistatin, an activinbinding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. J Biol Chem 266:19432-19437
17. Sidis Y, Schneyer AL, Keutmann HT 2005 Heparin and activin-binding determinants in follistatin and FSTL3. Endocrinology 146:130-136
18. Schneyer AL, Wang Q, Sidis Y, Sluss PM 2004 Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. J Clin Endocrinol Metab 89:5067-5075
19. Hayette S, Gadoux M, Martel S, Bertrand S, Tigaud I, Magaud JP, Rimokh R 1998 FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16:2949-2954
20. Schneyer A, Tortoriello D, Sidis Y, Keutmann H, Matsuzaki T, Holmes W 2001 Follistatin-related protein (FSRP): a new member of the follistatin gene family. Mol Cell Endocrinol 180:33-38
21. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL 2001 Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 142:3426-3434
22. Xia Y, Sidis Y, Schneyer A 2004 Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice. Mol Endocrinol 18:979-994
23. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL 2002 Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology 143:1613-1624
24. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, Qiu Y 2002 The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277:40735-40741
25. Lee SJ, McPherron AC 2001 Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98:9306-9311
26. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H 2000 Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family. J Biol Chem 275:40788-40796
27. Otsuka F, Moore RK, Iemura S, Ueno N, Shimasaki S 2001 Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun 289:961-966
28. Keutmann HT, Schneyer AL, Sidis Y 2004 The role of follistatin domains in follistatin biological action. Mol Endocrinol 18:228-240
29. McConnell DS, Wang QF, Sluss PM, Bolf N, Khoury RH, Schneyer AL, Midgley Jr. AR, Reame NE, Crowley Jr WF, Padmanabhan V 1998 A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab 83:851-858
30. Bernstein JR, Crowley Jr WF, Schneyer AL 1990 An improved method of purifying inhibin radioligand for radioimmunoassay. Biol Reprod 43:492-496
31. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley Jr WF 1994 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 135:667-674
32. Korchynskyi O, Ten Dijke P 2002 Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277:4883-4891
33. Dennler S, Itoh S, Vivien D, Ten Dijke P, Huet S, Gauthier JM 1998 Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100
34. Shikone T, Matzuk MM, Perlas E, Finegold MJ, Lewis KA, Vale W, Bradley A, Hsueh AJW 1994 Characterization of gonadal sex cord-stromal tumor cell lines from inhibin α and p53-deficient mice: the role of activin as an autocrine growth factor. Mol Endocrinol 8:983-995
35. Wang X, Zeng W, Murakawa M, Freeman MW, Seed B 2000 Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression. J Virol 74:11296-11303
36. Hashimoto O, Kawasaki N, Tsuchida K, Shimasaki S, Hayakawa T, Sugino H 2000 Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin. Cell Signal 12:565-571
37. Di Simone N, Hall HA, Welt C, Schneyer AL 1998 Activin regulates βA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells. Endocrinology 139:1147-1155
38. Shimasaki S, Moore RK, Otsuka F, Erickson GF 2004 The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25:72-101
39. Bilezikjian LM, Corrigan AZ, Blount AL, Vale WW 1996 Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. Endocrinology 137:4277-4284
40. Corrigan AZ, Bilezikjian LM, Carroll RS, Bald LN, Schmelzer CH, Fendly BM, Mason AJ, Chin WW, Schwall RH, Vale W 1991 Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 128:1682-1684
41. Bauer-Dantoin AC, Weiss J, Jameson JL 1996 Gonadotropin-releasing hormone regulation of pituitary follistatin gene expression during the primary follicle-stimulating hormone surge. Endocrinology 137:1634-1639
42. Besecke LM, Guendner MJ, Schneyer AL, Bauer-Dantoin AC, Jameson JL, Weiss J 1996 Gonadotropin-releasing hormone regulates follicle-stimulating hormone-β gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology 137:3667-3673
43. Schneyer AL, Wang QF, Weiss J, Boepple P, Hall J, Khoury R, Taylor A, Pralong F, Sluss P, Crowley WF 1997 Follistatin physiology and potential mechanisms of action in the human. In: Aono T, Sugino H, Vale WW, eds. Inhibin, activin and follistatin: regulatory functions in system and cell biology. New York: Springer-Verlag; 28-38
44. Lin HK, Bergmann S, Pandolfi PP 2004 Cytoplasmic PML function in TGF-β signalling. Nature 431:205-211
45. Panopoulou E, Gillooly DJ, Wrana JL, Zerial M, Stenmark H, Murphy C, Fotsis T 2002 Early endosomal regulation of Smad-dependent signaling in endothelial cells. J Biol Chem 277:18046-18052
46. Itoh F, Divecha N, Brocks L, Oomen L, Janssen H, Calafat J, Itoh S, Dijke PP 2002 The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-β/Smad signalling. Genes Cells 7:321-331
47. Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino S 1997 A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. J Biol Chem 272:13835-13842
48. Saito S, Sidis Y, Mukherjee A, Xia Y, Schneyer A 2005 Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3 (fstl3). Endocrinology 146:5052-5062
49. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K 2004 Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol 270:19-30
50. Iemura I, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N 1998 Direct binding of follistatin to a complex of bonemorphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 95:9337-9342
51. Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS 2005 The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev Cell 9:535-543
52. Thompson TB, Woodruff TK, Jardetzky TS 2003 Structures of an ActRIIB: activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions. EMBO J 22:1555-1566